(5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one(CAS: 65-04-3)

The compound (5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one (CAS: 65-04-3) is subject to various regulatory guidelines including GHS classification for hazardous materials, REACH regulations for European manufacturers and importers, and FDA/EPA requirements for pharmaceutical and environmental safety. It is also important to comply with local and regional regulations.

In synthesis, alternatives to (5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one (CAS: 65-04-3) include its analogs and isomers, such as testosterone or dihydrotestosterone. Common alternative reagents include methylene chloride, acetic anhydride, and other synthetic equivalents, depending on the specific application.

The market for (5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one (CAS: 65-04-3) is driven by its use in research and development of hormones and related pharmaceuticals. Recent trends show increasing interest in its application in anti-aging treatments and sports supplements. Research is also focusing on its potential in endocrine studies and drug discovery.

Waste containing (5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one (CAS: 65-04-3) should be collected in a closed container and disposed of by incineration or through professional waste disposal services. Environmental protection measures include proper labeling and containing to prevent leakage, and following local waste management regulations.